What is a stock summary page? Click here for an overview.
Business Description
IM Cannabis Corp
NAICS : 325412
SIC : 3741
ISIN : CA6392941077
Compare
Compare
Traded in other countries / regions
IMCC.CanadaIMCC.USANRKN.Germany IPO Date
2021-03-01Description
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.13 | |||||
| Equity-to-Asset | 0.13 | |||||
| Debt-to-Equity | 2.63 | |||||
| Debt-to-EBITDA | -2.67 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -7.77 | |||||
| Beneish M-Score | -3.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.6 | |||||
| 3-Year EBITDA Growth Rate | 50.3 | |||||
| 3-Year EPS without NRI Growth Rate | 28.2 | |||||
| 3-Year FCF Growth Rate | 36.8 | |||||
| 3-Year Book Growth Rate | -27.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 61.47 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 23.51 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.02 | |||||
| 9-Day RSI | 48.86 | |||||
| 14-Day RSI | 45.03 | |||||
| 3-1 Month Momentum % | 0.45 | |||||
| 6-1 Month Momentum % | -3.48 | |||||
| 12-1 Month Momentum % | -13.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | |||||
| Quick Ratio | 0.59 | |||||
| Cash Ratio | 0.05 | |||||
| Days Inventory | 63.47 | |||||
| Days Sales Outstanding | 71.48 | |||||
| Days Payable | 95.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -49.9 | |||||
| Shareholder Yield % | -40.4 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 12.87 | |||||
| Operating Margin % | -28.48 | |||||
| Net Margin % | -25.8 | |||||
| FCF Margin % | 5.33 | |||||
| ROE % | -118.02 | |||||
| ROA % | -29.19 | |||||
| ROIC % | -41.11 | |||||
| 3-Year ROIIC % | -29.93 | |||||
| ROC (Joel Greenblatt) % | -125.75 | |||||
| ROCE % | -65.25 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.1 | |||||
| PB Ratio | 0.95 | |||||
| Price-to-Free-Cash-Flow | 2.03 | |||||
| Price-to-Operating-Cash-Flow | 1.92 | |||||
| EV-to-EBIT | -2.25 | |||||
| EV-to-EBITDA | -3.17 | |||||
| EV-to-Forward-EBITDA | 9.55 | |||||
| EV-to-Revenue | 0.36 | |||||
| EV-to-Forward-Revenue | 0.28 | |||||
| EV-to-FCF | 7.1 | |||||
| Price-to-GF-Value | 0.43 | |||||
| Earnings Yield (Greenblatt) % | -44.44 | |||||
| FCF Yield % | 37.03 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:IMCC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IM Cannabis Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 37.897 | ||
| EPS (TTM) ($) | -4.283 | ||
| Beta | 1.52 | ||
| 3-Year Sharpe Ratio | -0.58 | ||
| 3-Year Sortino Ratio | -0.87 | ||
| Volatility % | 149.38 | ||
| 14-Day RSI | 45.03 | ||
| 14-Day ATR ($) | 0.157607 | ||
| 20-Day SMA ($) | 1.882495 | ||
| 12-1 Month Momentum % | -13.35 | ||
| 52-Week Range ($) | 1.61 - 8.099999 | ||
| Shares Outstanding (Mil) | 3.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
IM Cannabis Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
IM Cannabis Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
IM Cannabis Corp Frequently Asked Questions
What is IM Cannabis Corp(IMCC)'s stock price today?
The current price of IMCC is $1.85. The 52 week high of IMCC is $8.10 and 52 week low is $1.61.
When is next earnings date of IM Cannabis Corp(IMCC)?
The next earnings date of IM Cannabis Corp(IMCC) is 2025-03-31.
Does IM Cannabis Corp(IMCC) pay dividends? If so, how much?
IM Cannabis Corp(IMCC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers